Recombinant Human RAC3 Protein ，GST

RAC3, a member of the Rho family of GTPases, has garnered significant attention in recent years due to its pivotal role in various cellular processes, including cell proliferation, migration, and differentiation. This protein is involved in the regulation of cytoskeletal dynamics and is implicated in signaling pathways that promote cancer progression. Dysregulation of RAC3 activity has been associated with several malignancies, making it a potential target for therapeutic intervention. Recent studies have focused on the structural characterization and functional analysis of RAC3, particularly through the use of recombinant protein techniques. By producing and purifying RAC3 as a recombinant protein, researchers aim to elucidate its molecular mechanisms and interactions with downstream effectors. This research is critical for understanding how RAC3 contributes to tumorigenesis and for identifying novel strategies to inhibit its aberrant signaling in cancer cells. Advanced techniques such as X-ray crystallography and cryo-electron microscopy are increasingly utilized to gain insights into the three-dimensional structure of RAC3 and its complexes, paving the way for structure-based drug design. Overall, the study of RAC3 recombinant proteins is fundamental for advancing our knowledge of cellular regulation and developing targeted therapies for cancer treatments.